GW also had patents licensed for medication distributed in Europe without the U.S. Barriers to entry to that market, maybe CBIS would have real revenues to show for it
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.